Thomas Flaten Analyst Performance

Senior Research Analyst at Lake Street Capital

Thomas Flaten is a stock analyst at Lake Street Capital in the medical sector, covering 13 publicly traded companies. Over the past year, Thomas Flaten has issued 13 stock ratings, including buy and hold recommendations. While full access to Thomas Flaten's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Thomas Flaten's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 17 Last 5 Years
Buy Recommendations: 88.24% 15 Buy Ratings
Companies Covered: 13 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	88.2%	15 ratings
Hold	11.8%	2 ratings
Sell	0.0%	0 ratings

Out of 17 total stock ratings issued by Thomas Flaten at Lake Street Capital, the majority (88.2%) have been Buy recommendations, followed by 11.8% Hold.

Best & Worst Calls

Best Call
0000.0%
DMTK
Mar 2020
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
VCYT
Dec 2019
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	100.0% of companies on NASDAQ	13 companies

Thomas Flaten, an analyst at Lake Street Capital, currently covers 13 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 13 companies	100.0%

Thomas Flaten of Lake Street Capital specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 3 companies	23.1%
MED - DRUGS 2 companies	15.4%
MED INSTRUMENTS 2 companies	15.4%
MEDICAL SERVICES 2 companies	15.4%
PHARMACEUTICAL PREPARATIONS 2 companies	15.4%
MEDICAL INFO SYS 1 company	7.7%
MEDICAL LABORATORIES 1 company	7.7%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
DERM Journey Medical	8/13/2025	Boost Price Target	$7.33	$13.00	Buy
RPID Rapid Micro Biosystems	7/28/2025	Initiated Coverage	$4.08	$8.00	Buy
DMAC DiaMedica Therapeutics	7/18/2025	Boost Price Target	$3.93	$14.00	Buy
AYTU Aytu BioPharma	7/1/2025	Initiated Coverage	$2.18	$8.00	Buy
OCX OncoCyte	5/21/2025	Reiterated Rating	$3.44	$8.00	Buy
BDSX Biodesix	5/14/2025	Lower Price Target	$4.39	$40.00	Buy
CSTL Castle Biosciences	5/6/2025	Lower Price Target	$16.62	$35.00	Buy
OCX OncoCyte	3/28/2025	Initiated Coverage	$3.22	$5.00	Buy
OPTN OptiNose	3/20/2025	Downgrade	$6.00	$9.00	Hold
CKPT Checkpoint Therapeutics	3/10/2025	Reiterated Rating	$3.99	$4.10	Hold
AQST Aquestive Therapeutics	3/7/2025	Lower Price Target	$2.65	$8.00	Buy
EVAX Evaxion A/S	2/4/2025	Lower Price Target	$3.30	$6.00	Buy
OPTN OptiNose	1/16/2025	Lower Price Target	$6.13	$17.00	Buy

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.